Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, Wash.
Department of Laboratories, Seattle Children's Research Institute, Seattle, Wash; Department of Pathology, University of Washington School of Medicine, Seattle, Wash.
J Allergy Clin Immunol. 2022 Feb;149(2):685-697. doi: 10.1016/j.jaci.2021.07.014. Epub 2021 Jul 27.
Mast cells are involved in many distinct pathologic conditions, suggesting that they recognize and respond to various stimuli and thus require a rich repertoire of cell surface proteins. However, mast cell surface proteomes have not been comprehensively characterized.
We aimed to further characterize the mast cell surface proteome to obtain a better understanding of how mast cells function in health and disease.
We enriched for glycosylated surface proteins expressed in mouse bone marrow-derived cultured mast cells (BMCMCs) and identified them using mass spectrometry analysis. The presence of novel surface proteins in mast cells was validated by real-time quantitative PCR and flow cytometry analysis in BMCMCs and peritoneal mast cells (PMCs). We developed a clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) gene editing approach to disrupt genes of interest in BMCMCs.
The glycoprotein enrichment approach resulted in the identification of 1270 proteins in BMCMCs, 378 of which were localized to the plasma membrane. The most common protein classes among plasma membrane proteins were small GTPases, receptors, and transporters. One such cell surface protein was CD98 heavy chain (CD98hc), encoded by the Slc3a2 gene. Slc3a2 gene disruption resulted in a significant reduction in CD98hc expression, adhesion, and proliferation.
Glycoprotein enrichment coupled with mass spectrometry can be used to identify novel surface molecules in mast cells. Moreover, CD98hc plays an important role in mast cell function.
肥大细胞参与多种不同的病理状态,这表明它们能够识别和响应各种刺激,因此需要丰富的细胞表面蛋白库。然而,肥大细胞表面蛋白质组尚未得到全面描述。
我们旨在进一步描述肥大细胞表面蛋白质组,以更好地了解肥大细胞在健康和疾病中的功能。
我们从培养的骨髓来源的肥大细胞(BMCMCs)中富集表达的糖基化表面蛋白,并使用质谱分析进行鉴定。通过实时定量 PCR 和 BMCMCs 和腹膜肥大细胞(PMCs)中的流式细胞术分析验证肥大细胞中新型表面蛋白的存在。我们开发了一种簇状规则间隔短回文重复序列(CRISPR)/CRISPR 相关蛋白 9(Cas9)基因编辑方法来破坏 BMCMCs 中感兴趣的基因。
糖蛋白富集方法鉴定了 1270 种 BMCMCs 中的蛋白质,其中 378 种位于质膜上。质膜蛋白中最常见的蛋白类别是小 GTPases、受体和转运蛋白。其中一种细胞表面蛋白是 CD98 重链(CD98hc),由 Slc3a2 基因编码。Slc3a2 基因缺失导致 CD98hc 表达、黏附和增殖显著减少。
糖蛋白富集与质谱联用可用于鉴定肥大细胞中的新型表面分子。此外,CD98hc 在肥大细胞功能中发挥重要作用。